Consegna 30/70 Injection
Marketer
Wockhardt Ltd
Salt Composition
Insulin Isophane (70%) + Human insulin (30%)
Overview Consegna 30/70 Injection
Diabetic patients, both adult and pediatric, utilize the dual-insulin formulation of Consegna 30/70 Injection to manage blood glucose levels in type 1 and type 2 diabetes mellitus. This medication, a blend of intermediate and rapid-acting insulins, improves glycemic control and is typically administered in conjunction with other diabetes therapies. Subcutaneous injection, instructed by a healthcare professional, should occur 15 minutes prior to or within 20 minutes after meal initiation. Discontinuation requires physician approval. Effective diabetes management necessitates adherence to this medication, alongside a balanced diet, regular physical activity, and weight management as directed by your doctor. Consistent blood glucose monitoring and result reporting to your physician are crucial for dose optimization. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, preventable through precise dosing, consistent meals, and diligent blood sugar monitoring. Alcohol consumption may exacerbate hypoglycemia. Additional side effects include injection site reactions (redness, swelling), weight gain, rash, edema, and itching. Consegna 30/70 Injection is contraindicated in hypoglycemic states. Prior to initiating treatment, individuals with kidney, liver, or heart conditions, as well as pregnant or breastfeeding women, must consult their physician for appropriate dose adjustment.
Uses of Consegna 30/70 Injection
Managing Diabetes
Major Benefits of Consegna 30/70 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Consegna 30/70 Injection:
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use Consegna 30/70 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Consegna 30/70 Injection works:
Isophane insulin provides sustained blood sugar management, whereas rapid-acting human insulin offers immediate glucose control. Their combined effect achieves consistent blood glucose levels by promoting glucose uptake in muscle and adipose tissues and reducing hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Consegna 30/70 Injection is inadvisable.
PregnancySAFE IF PRESCRIBED
Administration of Consegna 30/70 Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Administering 30/70 Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Administering Consegna 30/70 Injection requires careful consideration in individuals with impaired renal function. Dosage modification for Consegna 30/70 Injection might be necessary. Physician consultation is advised. Routine blood glucose monitoring is suggested to guide dosage changes.
LiverCAUTION
Administering Consegna 30/70 Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Consegna 30/70 Injection might be necessary. Physician consultation is recommended.
What if you forget to take Consegna 30/70 Injection :
Delayed administration of Consegna 30/70 Injection may result in elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust subsequent dosing as needed.
Facts to Know About Consegna 30/70 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently